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Background: Promoting safer sex behaviours among people who inject drugs is important as drug-using populations
with high HIV prevalence can contribute to transition from a concentrated to a generalised epidemic. This study
describes the sexual behaviours of men who inject drugs in two Northeast Indian states (Manipur and Nagaland)
where HIV prevalence is high, with a focus on the HIV risks for their regular female sexual partners.
Methods: Data were obtained from two cross-sectional surveys combined (N = 3,362)—both conducted in 2009 using
respondent-driven sampling to recruit men who injected drugs. Both surveys asked about demographics, drug use,
sexual and injecting risk behaviours, and interventions. One survey tested participants for HIV and syphilis. Statistical
analyses included logistic regression modelling to predict inconsistent condom use with regular sexual partners.
Results: Two thirds of participants (68.2%) had a regular female sexual partner. Of these, 78.4% had sex with their
regular partner in the last month, on average five times. Only 10.7% reported consistent condom use with regular
partners. Unsafe injecting was common among men with regular partners, and 40.2% had more than one sexual
partner in the last year. Half of those with regular partners (51.0%) had never had an HIV test, and 14.3% of those
tested were HIV positive. After controlling for confounding, inconsistent condom use with regular partners was
associated with being illiterate, married, sharing needle and syringe with others, never having had an HIV test and
not receiving condoms from an NGO.
Conclusion: The findings from this study among men who inject drugs in Manipur and Nagaland highlight the risk
of HIV infection for their regular female sexual partners. Promoting better uptake of HIV testing among men who inject
drugs will potentially benefit both them and their regular partners. While effectively reaching regular partners is
challenging, a number of strategies for improving their situation in relation to HIV prevention are available.
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There are an estimated 16 million people who inject
drugs (PWID) in the world, of which three million are
thought to be HIV positive [1]. While the injecting be-
haviours of PWID are relatively well documented, much
less is known about their sexual behaviours, and it is
likely that sexual behaviours among PWID vary depend-
ing on the context. Most HIV prevention programs
targeting PWID focus primarily on the promotion of
safe injecting practices and the distribution of injecting* Correspondence: mkermode@unimelb.edu.au
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unless otherwise stated.equipment and are less vigilant about preventing sexual
transmission of HIV [2,3]. The prevention of sexual
transmission from PWID to their regular partners is im-
portant as PWID populations with high HIV prevalence
can contribute to the transition from a concentrated HIV
epidemic mainly affecting particular population sub-
groups (such as PWID, men who have sex with men, and
female sex workers) to a more generalised heterosexual
epidemic as has possibly happened in Argentina, Brazil,
China, Indonesia, Netherlands and Ukraine [4].
The majority of PWID in India are male and overall
7% are HIV positive, but this varies substantially depend-
ing on location. For example, prevalence in the state of
Punjab is 21%, while in other states, such as Karnataka,al. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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have regular female sexual partners (henceforth referred
to as regular partners), most of whom are at high risk of
HIV infection due to unprotected sex with their regular
(injecting) partner/husband [6,7]. Studies in Chennai
[8-10], Manipur [11-13], Delhi [11,14], and nationally
[15] have described HIV risks for regular female partners
of men who inject drugs, while other studies from
Chennai [8,10] and Manipur [12,16] have demonstrated
HIV transmission from HIV-positive men who inject
drugs to their regular sexual partners, with HIV prevalence
among the regular partners ranging from 16% in Chennai
(in 2003) [8,12] to 45% in Manipur (in 1996/97) [12].
The Northeast Indian states of Manipur and Nagaland
have been responding to the dual problems of injecting
drug use and a consequent HIV epidemic for more than
a decade [6]. It is estimated that 4% of adult males in
Manipur and 3% in Nagaland are injecting drugs, and
high levels of needle and syringe sharing have been re-
ported [6]. According to HIV Sentinel Surveillance, HIV
prevalence among PWID in these two states has ranged
between 28.6% in 2008/09 and 12.9% in 2010/11 in
Manipur, and between 8.4% in 2003 and 1.9% in 2007 in
Nagaland [5]. A cross-sectional survey of 1,700 PWID in
selected districts of Manipur and Nagaland in 2006 re-
ported an HIV prevalence of 23% in Bishnupur district
and 32% in Churachandpur district of Manipur and <2%
in two districts of Nagaland [17]. Conversely, the preva-
lence of syphilis was lower in Manipur (5.7% in Bishnupur
district, 0.9% in Churachandpur district) compared with
Nagaland (7.4% in Phek, 19.5% in Wokha) [17]. HIV
prevalence among women attending antenatal clinics in
Manipur has ranged between 1.7% in 2004 and 0.5% in
2009, and in Nagaland between 2% in 2005 and 0.7% in
2010/11 [5]. As in the rest of India, the HIV prevention re-
sponse in Manipur and Nagaland is led by the government
through the National AIDS Control Organization (NACO)
and the respective State AIDS Control Societies. Alongside
this, Avahan (the Bill & Melinda Gates Foundation’s
HIV initiative in India) funded Project ORCHID to co-
ordinate a range of local non-government organisa-
tions to implement HIV prevention interventions
in selected districts of Manipur and Nagaland over a
10-year period (2004/14) [18].
The majority of PWID in Manipur and Nagaland are
male, and many have regular female sexual partners in-
cluding wives, most of whom do not inject drugs [19].
As has been reported elsewhere in India [8-10], wives
are often not aware of their husband’s injecting behav-
iour at the time of marriage, the majority remain faithful
to their husbands and most do not know their husbands’
HIV status. Given the high prevalence of HIV and syphilis
among men who inject drugs in Manipur and Nagaland, it
is important to understand more about their sexualbehaviours generally and the HIV risks for their regular fe-
male sexual partners in particular. The objectives of this
study were as follows:
1. To describe the sexual behaviours of men who inject
drugs in Manipur and Nagaland and
2. To describe the HIV risks for the regular female
sexual partners of male PWID.
While previous studies have highlighted the problem
of HIV risks for the regular sexual partners of men who
inject drugs in India [8-10,12,15,16], the weight of
evidence needs to be stronger so that appropriate pre-
ventive interventions can be designed, funded and im-
plemented. Our study directly contributes to this body
of evidence and provides an update of the situation in
Manipur and Nagaland. Information from studies such
as this one can be used to advocate for and develop ef-
fective HIV prevention programs that protect not only
men who inject drugs but also their regular sexual
partners.
Methods
Data for this study were obtained from two separate
cross-sectional surveys: the Integrated Behavioural and
Biological Assessment (IBBA) conducted in two districts
of Manipur (Churachandpur, Bishnupur) and Nagaland
(Wokha, Phek) and the Behavioural Tracking Survey
(BTS) also conducted in two districts of Manipur (Chandel,
Ukhrul) and Nagaland (Kiphere, Zunheboto). Both surveys
collected information from men who inject drugs during
2009 using an interviewer-administered questionnaire and
the same sampling approach (discussed below). As the BTS
questionnaire was adapted from the IBBA questionnaire,
many of the questions were the same, so it was feasible to
combine data pertaining to variables common to both data-
sets, incorporating all eight districts. The methods for both
the IBBA and BTS have been described in-depth elsewhere
[20,21]. The inclusion criteria for both surveys were being
male aged 18 years or older and having injected drugs for
non-medical purposes at least once during the last 6
months. The IBBA was a central component of the Avahan
programme’s evaluation strategy [22], and the BTS was im-
plemented by Project ORCHID to evaluate the impact of
its programme in non-IBBA districts.
Sampling
Both the IBBA and the BTS surveys used respondent-
driven sampling (RDS) to recruit study participants. In
brief, RDS is a sampling method based on social network
theory and devised for more representative recruitment of
hidden populations such as PWID [23-25]. Respondent-
driven sampling uses peer networks for recruitment of
participants and involves payment of purposively recruited
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seed participants are given uniquely coded coupons to
recruit three eligible participants from their personal net-
works. The new recruits are invited to attend a nominated
RDS site, taking along their coded coupons. These new
participants are in turn provided with recruitment cou-
pons to share with their networks. This peer-to-peer par-
ticipant recruitment process continues until the desired
sample size is achieved. All participants are compensated
for their participation and for new recruits linked to them.
For both the IBBA and BTS, a sample size of 400 per
district was estimated based on an ability to detect
changes in proportions of 15% at follow-up surveys from
estimated baseline values of 50% (which yield the biggest
sample size), an alpha level of 0.05 and a power of 90%.
A design effect of 1.5 was applied to account for intra-
class correlation. A total of 1,650 participants were re-
cruited for the IBBA (Churachandpur 411, Bishnupur
410, Phek 418, Wokha 411), and a total of 1,712 partici-
pants were recruited for the BTS (Ukhrul 421, Chandel
415, Kiphere 427, Zunheboto 449). The combined data-
set included a total of 3,362 PWID, which represent
approximately 10% of the estimated number of PWID in
the two states [26].
Data collection
An anonymous, interviewer-administered, structured
questionnaire was used to gather information regard-
ing socio-demographics, drug use, sexual and injecting
risk behaviours, knowledge of HIV and exposure to in-
terventions. Additionally, the IBBA survey collected
blood specimens that were tested for HIV and a range
of STIs including syphilis. A regular partner was
defined as a regular non-paid sexual partner such as a
wife, spouse or girlfriend, and consistent condom use
was defined as every time. Sero-prevalence of HIV in-
fection was determined by using two test algorithms at
the state laboratory (screening test: Microlisa—HIV by J.
Mitra and Co. Pvt. Ltd.; confirmatory test: Genedia HIV1/
2 ELISA 3.0 by Greencross Life Sciences Corp) [27].
Statistical analysis
Descriptive data obtained using RDS is typically analysed
using purpose-designed statistical software (RDSAT) to
account for the complex sampling design. However, it is
not possible to undertake bivariate or multivariable ana-
lysis using RDSAT, although this is possible using stand-
ard statistical software, such as Stata or R, with weights
generated in RDSAT using the RDS network coding sys-
tem. As our analyses are based on data combined from
two RDS surveys conducted in eight districts across
Manipur and Nagaland, we did not believe it would be
legitimate to treat the data as one large RDS study be-
cause the RDS data collection coding systems wereunique to each district. All analyses were performed
using SPSS version 21 without adjustment for the com-
plex sampling design. Consequently, the results should
be viewed as if the sample were a large convenience one.
The chi-square test was used to examine differences be-
tween categorical variables and the independent-sample
t test for differences between continuous variables. Both
bivariate and multivariable logistic regression analyses
generated odd ratios (OR) with 95% confidence intervals
(CI). We speculated that having a regular sexual partner
may reduce the risk of engaging in unsafe sexual and
injecting behaviours, so compared participants with regu-
lar partners to those without in relation to these behav-
iours, excluding those who had never had sex. We also
examined the HIV risks for the regular partners of those
men from the IBBA dataset who were found to be HIV
positive.
Binary logistic regression modelling was used to iden-
tify factors associated with inconsistent condom use with
regular female sexual partners. Variables considered for
inclusion in the model were tested for co-linearity with
the outcome variable, and co-linear variables such as
‘consistent condom use with casual partners’ were ex-
cluded. The variables ultimately included in the model
were state, age group, literacy, marital status, shared at
last injection, generally injects with needle and syringe
used by another, number shared with during the last
month, number of female sexual partners in the last year,
frequency of sex with regular partner in the last month,
length of relationship with regular partner, had casual sex
in the past year, ever had an HIV test and receiving con-
doms from an NGO in the last year.
Ethics
Ethical clearance for the IBBA was obtained in India
through the Ethical Review Boards of the participating in-
stitutions: FHI360, the Regional Medical Research Centre
(RMRC) in Dibrugarh and the National AIDS Research
Institute (NARI). Ethical clearance for the BTS was
obtained from the Institutional Review Board of the
Emmanuel Hospital Association (EHA), New Delhi. Writ-
ten informed consent was obtained from all participants
prior to administration of the behavioural questionnaire
and biological testing, and confidentiality was assured.
Results
Demographic and other background information
The total sample size was 3,362 (1,657 Manipur, 1,705
Nagaland). The mean age of participants was 27.8 years
(29.6 years in Manipur, 26.2 years in Nagaland; median
26 years; range 18–57 years). Literacy was relatively high
at 84.6%, although it was better in Manipur (90.9%) than
in Nagaland (78.4%). Half of the sample was employed,
and the other half was either unemployed or students.
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currently married (Table 1).
The mean duration of injecting was 4.9 years (median
2 years; range 0–34 years; 6.5 years in Manipur, 3.3 years
in Nagaland). Heroin was the drug most commonly
injected in Manipur (95.2%), while other drugs, particularly
Spasmo-proxyvon (a pharmaceutical synthetic narcotic
containing dextropropoxyphene), were more common in
Nagaland (84.0%). Slightly less than half of the participants
overall (45.6%) injected at least once daily, but this was true
for two thirds in Manipur (67.5%). The practice of sharing
needles and syringes was relatively common, especially in
Nagaland. Overall, 16.6% of participants reported sharing at
their last injection, but 30.2% did so in Nagaland, and
34.0% said they generally injected with a syringe previously
used by someone else (no state differences). Overall, 27.0%
had shared with at least one other during the last month,
but this was true for 40.5% in Nagaland (Table 2).Table 1 Background information for men who inject






n (%) n (%) n (%)
District
Churachandpur 411 (24.8) 411 (12.2)
Bishnupur 410 (24.7) 410 (12.2)
Chandel 415 (25.0) 415 (12.3)
Ukhrul 421 (25.4) 421 (12.5)
Wokha 411(24.1) 411 (12.2)
Phek 418 (12.5) 418 (12.4)
Kiphere 427 (25.0) 427 (12.7)
Zunheboto 449 (26.3) 449 (13.4)
Age (years)a
<20 39 (2.4) 130 (7.6) 169 (5.0)
20–29 846 (51.1) 1,135 (66.6) 1,981 (58.9)
30–39 621 (37.5) 399 (23.4) 1,020 (30.3)
≥40 151 (9.1) 41 (2.4) 192 (5.7)
Literatea
No 150 (9.1) 368 (21.6) 518 (15.4)
Yes 1,507 (90.9) 1,337 (78.4) 2,844 (84.6)
Employment statusa
Unemployed 602 (36.4) 764 (44.9) 1,366 (40.7)
Student 78 (4.7) 223 (13.1) 301 (9.0)
Employed 976 (58.9) 716 (42.0) 1,692 (50.4)
Marital statusa
Married 605 (36.5) 514 (30.2) 1,119 (33.3)
Widowed/divorced/separated 151 (9.1) 61 (3.6) 212 (6.3)
Never married 901 (54.4) 1,127 (66.2) 2,028 (60.4)
ap < 0.001.HIV prevalence among the IBBA participants was
16.1%, and 8.7% had reactive syphilis serology, but major
state differences were observed. HIV prevalence in the
two districts of Manipur was 30.8% compared with 1.4%
in the two districts of Nagaland. Conversely, 13.4% in
Nagaland had reactive syphilis serology, compared with
3.9% in Manipur. Participation in HIV testing was sub-
optimal as 52.4% had never had an HIV test, but uptake
of HIV testing in Manipur (53.0%) was better than in
Nagaland (42.0%). Overall, 75.2% had received needles
and syringes from an NGO, and 58.2% had received
condoms, but coverage of both these services was
much better in Manipur (Table 2).Sexual behaviours of men who inject drugs in Manipur
and Nagaland
Most participants (89.9%) were sexually experienced.
Among those who had ever had sex, the mean number
of female sexual partners during the previous year was
2.23 (median 1; range 0–40), and more than two thirds
(68.2%) had a regular female sexual partner. One tenth
(9.4%) had paid for sex in the last year, and 34.4% had
casual sex in the last year. Condom use with both casual
and paid partners was sub-optimal: less than half
(44.9%) consistently used condoms with their paid
partners and only 28.7% with their casual partners.
The proportion reporting having ever had sex with a
man was small (2.4%). Participants from Nagaland
were generally more sexually active than those from
Manipur as evidenced by more sexual partners, more
sex with their regular sexual partners, and greater like-
lihood of casual sex, while the Manipuri participants
were more likely to pay for sex and to report sex with
a man (Table 2).HIV risks for the regular female sexual partners of men
who inject drugs in Manipur and Nagaland
Of the 68.2% who had a regular female sexual partner,
79.8% had been with this partner for at least 1 year.
Most (88.0%) reported sex with their regular partner
in the last month, on average five times (median 2;
range 0–61). Condom use with regular partners was
poor: 40.6% used a condom the last time they had sex
with their regular partners, and only 10.7% reported
consistent condom use with their regular partners
(Table 2).
Many participants with regular partners (40.2%) had
more than one sexual partner in the last year, 29.5% had
casual sex and 6.1% paid for sex in the last year. Consist-
ent condom use with casual sexual partners was 32.9%
and with paid partners was 36.5%. Half of those with
regular partners (51.0%) had never had an HIV test, and
14.3% were HIV positive (Table 3).
Table 2 HIV risk information for men who inject drugs in






n (%) n (%) n (%)
Injecting behaviours
Duration of injecting (years)a
≤1 285 (17.3) 471 (27.8) 756 (22.6)
2–5 636 (38.5) 943 (55.7) 1,579 (47.2)
6–10 422 (25.6) 234 (13.8) 656 (19.6)
>10 307 (18.6) 46 (2.7) 353 (10.6)
Most common drug injecteda
Heroin 1,578 (95.2) 273 (16.0) 1,851 (55.1)
SP and others 79 (4.8) 1,432 (84.0) 1,511 (44.9)
Injects at least once dailya
No 525 (32.5) 1,174 (77.9) 1,699 (54.4)
Yes 1,090 (67.5) 333 (22.1) 1,423 (45.6)
Shared NS at last injectiona
No 1,598 (96.5) 1,118 (69.8) 2,716 (83.4)
Yes 58 (3.5) 484 (30.2) 542 (16.6)
Generally injects with a previously used syringe
No 1,089 (66.0) 1,113 (66.1) 2,202 (66.0)
Yes 562 (34.0) 571 (33.9) 1,133 (34.0)
Number of people shared with during the last montha
None 1,368 (86.3) 939 (59.5) 2,307 (73.0)
≥1 217 (13.7) 638 (40.5) 855 (27.0)
Sexual behaviours
Ever had sexa
No 205 (12.4) 136 (8.0) 341 (10.1)
Yes 1,452 (87.6) 1,568 (92.0) 3,020 (89.9)
No. of female partners in the last year*a
None 301 (20.7) 112 (7.3) 413 (13.8)
One 758 (52.2) 588 (38.2) 1,346 (45.0)
2–5 329 (22.7) 653 (42.5) 982 (32.8)
≥6 64 (4.4) 185 (12.0) 249 (8.3)
Has a regular partner*a
No 608 (41.9) 351 (22.5) 959 (31.8)
Yes 844 (58.1) 1,208 (77.5) 2,052 (68.2)
Time with regular partnera
<1 year 104 (12.3) 307 (25.9) 411 (20.2)
≥1 year 739 (87.7) 880 (74.1) 1,619 (79.8)
No. of times had sex with regular partner in the
last montha
0 182 (21.6) 64 (5.3) 246 (12.0)
1–5 415 (49.2) 720 (59.6) 1,135 (55.3)
6–10 143 (16.9) 282 (23.3) 425 (20.7)
>10 104 (12.3) 142 (11.8) 246 (12.0)
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n (%) n (%) n (%)
Used condom with regular partner last time
No 486 (58.6) 716 (59.9) 1,202 (59.4)
Yes 343 (41.4) 479 (40.1) 822 (40.6)
Consistent condom use with regular partner
No 754 (90.6) 1,054 (88.3) 1,808 (89.3)
Yes 78 (9.4) 139 (11.7) 217 (10.7)
Had casual sex in the last year*a
No 1,104 (76.0) 864 (55.8) 1,968 (65.6)
Yes 348 (24.0) 684 (44.2) 1,032 (34.4)
Used condom with casual partner last timea
No 128 (36.1) 173 (24.9) 301 (28.6)
Yes 227 (63.9) 523 (75.1) 750 (71.4)
Consistent condom use with casual partnersa
No 280 (78.7) 472 (67.6) 752 (71.3)
Yes 76 (21.3) 226 (32.4) 302 (28.7)
Paid for sex in the last year*a
No 1,258 (86.6) 1,468 (94.2) 2,726 (90.6)
Yes 194 (13.4) 90 (5.8) 284 (9.4)
Used condom with a paid partner last timea
No 15 (7.7) 23 (24.7) 38 (13.2)
Yes 179 (92.3) 70 (75.3) 249 (86.8)
Consistent condom use with paid partners
No 101 (52.1) 57 (61.3) 158 (55.1)
Yes 93 (47.9) 36 (38.7) 129 (44.9)
Ever had sex with a mana
No 1,590 (96.1) 1,686 (99.0) 3,276 (97.6)
Yes 64 (3.9) 17 (1.0) 81 (2.4)
HIV and syphilis
Feels at risk of HIV
No 780 (49.6) 734 (51.5) 1,514 (50.6)
Yes 791 (50.4) 690 (48.5) 1,481 (49.4)
Ever had an HIV testa
No 777 (47.0) 941 (58.0) 1,718 (52.4)
Yes 877 (53.0) 681 (42.0) 1,558 (47.6)
HIV positive**a
No 568 (69.2) 817 (98.6) 1,385 (83.9)
Yes 253 (30.8) 12 (1.4) 265 (16.1)
Syphilis positive**a
No 789 (96.1) 718 (86.6) 1,507 (91.3)
Yes 32 (3.9) 111 (13.4) 143 (8.7)
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n (%) n (%) n (%)
Programme exposure
Received condoms from NGOa
No 628 (37.9) 777 (45.9) 1,405 (41.8)
Yes 1,029 (62.1) 927 (54.4) 1,956 (58.2)
Received NS from NGOa
No 203 (12.3) 631 (37.0) 834 (24.8)
Yes 1,454 (87.7) 1,074 (63.0) 2,528 (75.2)
NS = needle and syringe/s.
ap < 0.001.
*Among those reporting ever having sex. **Those from the IBBA database only.
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regular female sexual partners with those who did not
The men with regular partners were more likely to have
shared needles and syringes at their last injection (20.7%
cf 9.1%; p < 0.001), to have shared in the last month
(31.5% cf 20.4%; p < 0.001) and in fact had shared with
more people in the last month (0.97 cf 0.48; p < 0.001)
compared to those without a regular partner. One third
of those with regular partners (34.3%) generally injected
with needles and syringes previously used by others, but
this was similar to the proportion with no regular part-
ner (36.1%). Those with regular partners reported the
same number of sexual partners over the past year as
those with no regular partners (2.48 cf 2.09; NS) but
were less likely to report casual (29.5% cf 44.5%; p <
0.001) and paid sex (6.1% cf 16.6%; p < 0.001). They were
also less likely to consistently use condoms for paid sex
(36.5% cf 51.2%; p = 0.013), but more likely with casual
sex (32.9% cf 21.6%; p < 0.001).HIV risks for regular female sexual partners of HIV-
positive men
Among the 265/1,650 participants (16.1%) who were
found to be HIV positive in the IBBA survey, 57.5% had
a regular female sexual partner. Most (89.1%) reported
sex with their regular partner in the last month, on aver-
age of five times (median 3; range 0–30). Of these, only
half (49.6%) reported using a condom the last time they
had sex with their regular partner, and only 10.9% re-
ported consistent condom use, which is much the same
as the entire sample of men with regular partners. Even
though 82.0% of the HIV-positive participants thought
they were at risk of acquiring HIV, 38.5% had never pre-
viously been tested, so were presumably unaware of their
HIV-positive status.Factors associated with inconsistent condom use with
regular female sexual partners
Inconsistent condom use with regular partners was asso-
ciated with being older, being illiterate, being married,
unsafe injecting (at last injection, generally and sharing
with others), having fewer female sexual partners, having
more frequent sex and a longer relationship with the
regular partner, not having casual sex, inconsistent
condom use with casual partners, and not receiving
condoms from an NGO (Table 3). After controlling
for confounding, inconsistent condom use with regu-
lar partners was associated with being illiterate (OR
0.58; 95% CI 0.34, 0.99), being married (OR 5.23; 95%
CI 3.28, 8.33), sharing needle and syringe with others
in the past month (OR 2.71; 95% CI 1.51, 4.86), never
having had an HIV test (OR 0.68; 95% CI 0.49, 0.94)
and not receiving condoms from an NGO (OR 0.61;
95% CI 0.43, 0.86) (Table 3). Those participants who
had been married were five times more likely to be in-
consistent condom users with their regular partners,
and those who had shared with at least one other in
the last month were almost three times more likely to
be inconsistent condom users. Those who were liter-
ate and those who had received condoms from an
NGO were 40% less likely to be an inconsistent con-
dom user with their regular partner, and those who
had previously had an HIV test were 30% less likely.Discussion
The findings from this large cross-sectional dataset
highlight that the majority of men who inject drugs in
Manipur and Nagaland were engaging in risk behav-
iours, including sexual risk behaviours, that placed
themselves and their regular and non-regular female
sexual partners at risk of HIV infection.
Men who inject drugs in these two states were clearly
sexually active. A large majority of participants (90%)
had experienced sex, and most of them had been sexu-
ally active in the previous year, with 41% reporting two
or more sexual partners during that time. The partici-
pants from Nagaland were more sexually active than
those from Manipur, which may be due to a range of
factors including younger age, less chronic opiate de-
pendence and relatively infrequent use of heroin. In con-
trast to studies of sexual behaviour among PWID in
other parts of India [11,14], very few reported male-to-
male sexual experiences. Same-sex relationships are
strongly proscribed in these traditional societies, espe-
cially in Nagaland, which may contribute to relatively
fewer same-sex encounters as well as under-reporting of
such behaviours. Despite the implementation of scaled
interventions and consequent reductions in HIV risk
behaviours [21], consistent condom use with all
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from optimal.
The majority of the men in this study had regular fe-
male sexual partners, half of whom were wives, and the
risk of HIV transmission to these partners via unpro-
tected sex remains. Only 41% of participants said they
had used a condom the last time they had sex with their
regular partner, which is the same as the proportion re-
ported in a 2010 study among 300 men who had
injected drugs from three Northeast Indian states [28].
Consistent condom use with regular partners was only
11% overall (9% in Manipur and 12% in Nagaland),
which is particularly concerning in Manipur where HIV
prevalence among PWID is high. In a 2007 study among
men who inject drugs in Northeast Indian states, con-
sistent condom use with regular partners was reported
to be 19%, which indicates that the situation is not im-
proving [11].
The men with regular partners were placing them-
selves and their partners at risk of HIV through both un-
safe injecting and unsafe sexual behaviours. Those with
regular partners were just as likely to be sharing needles
and syringes as those without and were actually more
likely to report sharing at the most recent injection and
to have shared with more people. A recently published
study from Northeast India also observed a positive as-
sociation between unsafe injecting and unprotected sex
with regular partners [13]. Some with regular partners
were sexually active outside of their regular relationship,
and while they reported less casual and paid sex than
those with no regular partner, and condom use with cas-
ual and paid partners was better than with regular part-
ners, it was still not optimal.
After controlling for confounding, inconsistent con-
dom use with regular partners was associated with being
married, poor literacy, sharing needles and syringes in
the last month, having never had an HIV test and not
receiving condoms from an NGO. Consistent condom
use in the context of a regular committed relationship,
especially marriage, is notoriously difficult to achieve for
many people, not only PWID [29,30]. Marriages are gen-
erally based on a shared desire for intimacy and mutual
trust: consequently, introducing condoms into the rela-
tionship is often unwanted and difficult to navigate (es-
pecially if the couple are wanting to have children), so a
range of alternative strategies have to be made available
for the wives and other regular sexual partners of men
who inject drugs. The association between more consist-
ent condom use and having ever had an HIV test could
be due to the fact that some of the men who had previ-
ously been tested knew themselves to be HIV infected,
but when the sub-set of HIV-positive participants are ex-
amined, there seems to be no difference between them
and HIV-negative participants in terms of condom use.Alternatively, the risk reduction counselling provided at
the time of HIV testing may be promoting better con-
dom use. Also, it is probably the case that those who
had contact with NGOs were both more likely to receive
condoms and to be referred for HIV testing, suggesting
that NGOs have a positive role to play in promoting
safer sex among PWID.
A number of interventions could strengthen harm re-
duction programs in relation to the prevention of HIV
transmission due to unprotected sex. The findings indi-
cate that while three quarters of the participants are re-
ceiving needles and syringes from NGOs, only 58% are
receiving condoms. It is probable that distribution of
condoms alone is not sufficient to promote safer sexual
behaviours; changes in attitudes at the individual, couple
and social levels [7,8,31] and the development of negoti-
ation skills are also required. Peer educators in harm re-
duction programs are not necessarily trained to facilitate
such changes. It is probable that the current HIV pre-
vention programs in these two states could be strength-
ened in relation to the promotion of safe sex among
PWID, especially as the findings indicate that PWID
who receive condoms from NGOs are more likely to be
consistent condom users with their regular partners.
Peer educators could be up-skilled so that they are as
comfortable, conscientious and competent talking about
safe sex as they are about safe injecting. It is also import-
ant that the messages are conveyed using media that will
be easily understood by those with poor literacy. Evi-
dence from a meta-analysis of the effectiveness of 33
US-based interventions that aimed to reduce the sexual
risk behaviours of drug users demonstrated that targeted
interventions can contribute to sexual risk reduction
[32]. Additionally, the development of protocols and
practices to assist men who inject drugs to disclose their
HIV risks and status to their wives would be valuable, as
they often find it difficult to do this alone [10].
Ensuring easy access to HIV testing for PWID is im-
portant for both them and their partners, and clearly the
current level of uptake is not optimal. More than one
third of the HIV-positive participants with regular part-
ners had never had an HIV test, and those who had pre-
viously had a test may have done so while they were still
HIV negative, or may not have returned for the results.
Consequently, a significant proportion of the HIV-
positive participants would have been unaware of their
status. It was also evident that those PWID who had
previously had an HIV test were more likely to use con-
doms consistently with their regular partner. Other stud-
ies have reported a higher proportion of consistent
condom use among PWID who know they are HIV posi-
tive [29]. Identifying those men who are HIV infected
and referring them for antiretroviral therapy (ART) will
benefit them as well as their regular partners, as men on
Table 3 Factors associated with inconsistent condom use
with regular partners among PWID in Manipur and
Nagaland (2009)







Nagaland 1,208 (58.9) 0.78 (0.58, 1.05) 0.78 (0.54, 1.13)
Age group
<30 years 1,209 (58.9)
≥30 years 843 (41.1) 2.56 (1.84, 3.55) 1.19 (0.77, 1.85)
Literacy
Illiterate 314 (15.3)
Literate 1,738 (84.7) 0.60 (0.38, 0.95) 0.58 (0.34, 0.99)
Marital status
Never married 923 (45.0)
Ever married 1,127 (55.0) 5.11 (3.66, 7.13) 5.23 (3.28, 8.33)
Shared NS at last injection
No 1,593 (79.3)
Yes 415 (20.7) 2.48 (1.57, 3.91) 1.34 (0.68, 2.64)
Generally injects with NS previously used by other
No 1,337 (65.2)
Yes 699 (34.3) 2.03 (1.45, 2.84) 1.26 (0.82, 1.96)
Number of people shared with during the past month
None 1,329 (68.5)
≥1 610 (31.5) 2.56 (1.75, 3.75) 2.71 (1.51, 4.86)
No. of female partners in the last year
≤1 1,213 (59.8)
>1 816 (40.2) 0.57 (0.43, 0.76) 0.85 (0.52, 1.39)
No. of times had sex with regular partner in the last month
≤4 1,204 (58.7)
>4 848 (41.3) 1.54 (1.26, 1.90) 1.21 (0.95, 1.53)
Length of time with the regular partner
<1 year 411 (20.2)
≥1 year 1,619 (79.8) 1.80 (1.31, 2.48) 1.23 (0.86, 1.77)
Had casual sex in the last year
No 1,436 (70.5)
Yes 600 (29.5) 0.68 (0.51, 0.91) 1.43 (0.87, 2.35)
Consistent condom use with casual partners
No 410 (67.1%)
Yes 201 (32.9%) 0.44 (0.02, 0.09) ___
Paid for sex in the last year
No 1,919 (93.9)
Yes 124 (6.1) 1.56 (0.78, 3.13) ___
Table 3 Factors associated with inconsistent condom use
with regular partners among PWID in Manipur and
Nagaland (2009) (Continued)





Consistent condom use with paid partners
No 80 (63.5)
Yes 46 (36.5) 0.25 (0.06, 1.07) ___
Ever had an HIV test
No 1,029 (51.0)
Yes 990 (49.0) 0.87 (0.65, 1.15) 0.68 (0.49, 0.94)
Given condoms by NGO in the last year
No 827 (40.3)
Yes 1,224 (59.7) 0.63 (0.47, 0.85) 0.61 (0.43, 0.86)
Given needle and syringe by NGO in the last year
No 584 (28.5)
Yes 1,468 (71.5) 0.74 (0.54, 1.04) ___
HIV status*
Negative 854 (85.7)
Positive 142 (14.3) 0.96 (0.54, 1.72) ___
Syphilis status*
Negative 892 (89.6)
Positive 104 (10.4) 1.43 (0.67, 3.03) ___
*Data from the IBBA database only.
NS = needle and syringe/s.
NB: Bolded results are significant at p < 0.05.
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[33]. While acknowledging that the concept of ‘treat-
ment as prevention’ (TasP) is an appealing one, the ef-
fectiveness of this approach among HIV-infected PWID
has not been adequately demonstrated to date [34,35].
Reaching the regular partners of men who inject drugs
in order to provide HIV prevention services is challen-
ging because contact with these women is inevitably me-
diated by their male partners. Not all men who inject
drugs are willing to bring their regular partners to attend
such services [10], and not all regular partners are inter-
ested in attending. Additionally, some HIV prevention
programs are not mandated or funded to extend their
services directly to the regular partners of men who in-
ject drugs, unless they are engaging in injecting drug use
or sex work. Raising awareness of HIV risks, prevention,
diagnosis and treatment among regular partners of men
who inject drugs is important if the HIV epidemic is to
be effectively addressed. In the context of India, several
resources focusing on HIV prevention among regular fe-
male sexual partners of men who inject drugs are avail-
able, and these can be used to inform the development
of relevant policies and programs [28,36,37].
Kermode et al. Harm Reduction Journal  (2015) 12:4 Page 9 of 10This study has a number of limitations that should be
considered when interpreting the findings. We have
combined data collected across eight districts for the
IBBA and BTS surveys to construct a large convenience
sample, and consequently, our analyses did not account
for the complex sampling design. The limitation of this
approach is that the results are essentially based on a
convenience sample with restricted generalisability of
the observed associations. However, the sample size was
quite large, accounting for approximately 10% of the
PWID population in the two states [26]. Secondly, it is
highly probable that the participants’ responses to some
questions regarding their injecting and sexual risk be-
haviours were influenced by social desirability bias, and
this may have contributed to an under-estimation of
HIV risks for them and their partners. No data were col-
lected directly from regular female sexual partners them-
selves, so the study conclusions are based on data
collected from their male partners. Finally, since these
data were collected, several HIV prevention programs
have endeavoured to improve coverage for the regular
partners of PWID in these two states and there have
been targeted campaigns to increase the uptake of HIV
testing among PWID [38]. However, the impact of these
subsequent interventions has not yet been evaluated,
and the findings reported in this paper provide an im-
portant point of comparison for any subsequent evalua-
tions of more recent interventions.Conclusion
In summary, the findings from this study involving a
large number of men who inject drugs in the Northeast
Indian states of Manipur and Nagaland highlight the po-
tential risk of HIV infection for them and their regular
female sexual partners. While effectively reaching the
regular sexual partners of men who inject drugs is chal-
lenging, a number of strategies for improving their situ-
ation are available. These findings add to a growing body
of evidence supporting the need for government and
non-government agencies to strengthen the capacity of
harm reduction programs to promote safer sex among
PWID, improve their uptake of HIV testing and extend
HIV prevention services to their regular sexual partners,
especially in areas of the country where HIV prevalence
among PWID is high.
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